OPKO Health, Inc. Earnings Per Share (Basic)
OPKO Health, Inc. (OPK) reported Earnings Per Share (Basic) of -$0.01 per share for the 3-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-28
- OPKO Health, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.01.
- OPKO Health, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.07.
- OPKO Health, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.04, a 300.00% decline year-over-year.
- OPKO Health, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.03, a 25.00% decline year-over-year.
- OPKO Health, Inc. earnings per share, basic for fiscal 2025 was -$0.30.
- OPKO Health, Inc. earnings per share, basic for fiscal 2024 was -$0.08.
- OPKO Health, Inc. earnings per share, basic for fiscal 2023 was -$0.25.
- OPKO Health, Inc. earnings per share, basic for fiscal 2022 was -$0.46.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.01 10-Q/A · filed 2026-08-28 | -$0.08 10-Q/A · filed 2026-08-28 | |||
| 2026-03-31 | -$0.07 10-Q/A · filed 2026-08-28 | ||||
| 2025-12-31 | -$0.04 10-K · filed 2026-02-26 | -$0.30 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $0.03 10-K · filed 2026-02-26 | -$0.26 10-Q · filed 2025-10-29 | |||
| 2025-06-30 | -$0.19 10-Q/A · filed 2026-08-28 | -$0.31 10-Q/A · filed 2026-08-28 | |||
| 2025-03-31 | -$0.10 10-Q/A · filed 2026-08-28 | ||||
| 2024-12-31 | $0.02 10-K · filed 2026-02-26 | -$0.08 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $0.04 10-K · filed 2026-02-26 | -$0.10 10-Q · filed 2025-10-29 | |||
| 2024-06-30 | -$0.01 10-K · filed 2026-02-26 | -$0.13 10-Q · filed 2025-07-31 | |||
| 2024-03-31 | -$0.12 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | -$0.09 10-K · filed 2025-03-03 | -$0.25 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$0.11 10-K · filed 2025-03-03 | -$0.16 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$0.03 10-K · filed 2025-03-03 | -$0.05 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | -$0.02 10-K · filed 2025-03-03 | ||||
| 2022-12-31 | -$0.11 10-K · filed 2024-03-01 | -$0.46 10-K · filed 2025-03-03 | |||
| 2022-09-30 | -$0.11 10-K · filed 2024-03-01 | -$0.34 10-Q · filed 2023-11-06 | |||
| 2022-06-30 | -$0.14 10-K · filed 2024-03-01 | -$0.23 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | -$0.08 10-K · filed 2024-03-01 | ||||
| 2021-12-31 | -$0.11 10-K · filed 2023-02-27 | -$0.05 10-K · filed 2024-03-01 | |||
| 2021-09-30 | $0.04 10-K · filed 2023-02-27 | $0.07 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | -$0.03 10-K · filed 2023-02-27 | $0.02 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $0.05 10-K · filed 2023-02-27 | ||||
| 2020-12-31 | $0.05 10-K · filed 2022-03-01 | $0.05 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $0.04 10-K · filed 2022-03-01 | $0.00 10-Q · filed 2021-10-28 | |||
| 2020-06-30 | $0.05 10-K · filed 2022-03-01 | -$0.04 10-Q · filed 2021-07-29 | |||
| 2020-03-31 | -$0.09 10-K · filed 2022-03-01 | ||||
| 2019-12-31 | -$0.53 10-K · filed 2022-03-01 | ||||
| 2018-12-31 | -$0.27 10-K · filed 2020-03-02 | ||||
| 2018-06-30 | -$0.01 10-Q · filed 2018-08-07 | -$0.09 10-Q · filed 2018-08-07 | |||
| 2017-12-31 | -$0.39 10-K · filed 2019-03-01 | -$0.38 10-K · filed 2018-03-01 | -$0.55 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$0.06 10-K · filed 2019-03-01 | -$0.08 10-K · filed 2018-03-01 | |||
| 2017-06-30 | -$0.03 10-K · filed 2019-03-01 | -$0.09 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | -$0.06 10-K · filed 2019-03-01 | ||||
| 2016-12-31 | -$0.04 8-K · filed 2019-01-29 | -$0.02 10-K · filed 2017-03-01 | -$0.08 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$0.06 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$0.09 10-K · filed 2019-03-01 |
| 2016-09-30 | -$0.04 8-K · filed 2019-01-29 | -$0.03 10-Q · filed 2016-11-07 | -$0.02 derived: net income ÷ weighted average shares · filed 2019-01-29 | -$0.02 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $0.02 8-K · filed 2019-01-29 | $0.03 10-Q · filed 2016-08-08 | $0.01 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | -$0.03 8-K · filed 2019-01-29 | -$0.02 10-K · filed 2017-03-01 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 | $0.25 derived: net income ÷ weighted average shares · filed 2019-01-29 | $0.17 derived: net income ÷ weighted average shares · filed 2019-01-29 | -$0.11 8-K · filed 2019-01-29 | |
| 2015-09-30 | $0.26 10-K · filed 2017-03-01 | $0.18 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.07 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | -$0.09 10-K · filed 2017-03-01 | -$0.35 10-Q · filed 2016-08-08 | |||
| 2015-03-31 | -$0.26 10-K · filed 2017-03-01 | ||||
| 2014-12-31 | -$0.12 10-K · filed 2016-02-29 | ||||
| 2014-09-30 | -$0.11 10-K · filed 2016-02-29 | -$0.28 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | -$0.06 10-K · filed 2016-02-29 | ||||
| 2014-03-31 | -$0.11 10-K · filed 2016-02-29 | ||||
| 2012-03-31 | -$0.03 10-Q · filed 2012-05-10 | ||||
| 2011-12-31 | $0.06 10-K · filed 2013-03-18 | -$0.01 10-K · filed 2012-03-15 | |||
| 2011-09-30 | -$0.03 10-K · filed 2013-03-18 | ||||
| 2011-06-30 | -$0.02 10-K · filed 2013-03-18 | ||||
| 2011-03-31 | -$0.02 10-K · filed 2013-03-18 | ||||
| 2010-12-31 | -$0.08 10-K · filed 2012-03-15 | ||||
| 2009-12-31 | -$0.15 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |